Spinocerebellar ataxia type 10 (SCA10) is a progressive neurodegenerative disorder characterized by a wide array of symptoms. It is caused by mutations in the ATXN10 gene, which is inherited in an autosomal dominant pattern. This means that an individual only needs a single copy of the mutated gene from one parent to be affected by the disorder. SCA10 significantly impacts the coordination of muscle movements, leading to a progressive loss of motor control. DNA Labs UAE offers a comprehensive genetic test for the ATXN10 gene to help individuals and families understand their risk and manage the condition effectively.
Symptoms of Spinocerebellar Ataxia Type 10
SCA10 manifests through various symptoms, which typically begin in adulthood. These symptoms can vary widely among individuals, even among members of the same family. Some of the common symptoms include:
- Ataxia: The hallmark symptom of SCA10, characterized by a lack of muscle coordination that affects speech, eye movements, and the ability to swallow, walk, and perform fine motor tasks.
- Seizures: Epileptic seizures are a distinctive feature of SCA10, differing from other forms of spinocerebellar ataxia.
- Dysarthria: Difficulty in articulating words due to impaired movement of the muscles used for speech.
- Nystagmus: Involuntary eye movement, which can result in reduced vision or the perception that the world is shaking.
- Peripheral neuropathy: This involves damage to the peripheral nerves, leading to weakness, numbness, and pain usually in the hands and feet.
- Non-motor symptoms: These may include cognitive impairments, psychiatric disorders, and sleep disturbances.
The severity and progression of these symptoms can vary, making early diagnosis and management critical for improving the quality of life for those affected by SCA10.
ATXN10 Gene Spinocerebellar Ataxia Type 10 Autosomal Dominant Genetic Test
DNA Labs UAE offers a genetic test for SCA10, targeting the ATXN10 gene to identify mutations that cause the disorder. This test is essential for individuals with a family history of SCA10 or those exhibiting symptoms of the disorder. The genetic test involves a simple blood draw or cheek swab, with samples analyzed in a state-of-the-art laboratory. Results from the test can provide valuable information for diagnosis, treatment planning, and family planning decisions.
The cost of the ATXN10 gene spinocerebellar ataxia type 10 autosomal dominant genetic test is 4400 AED. While the cost may seem significant, the information gained from this test can be invaluable in managing the disorder and planning for the future.
Why Choose DNA Labs UAE?
DNA Labs UAE is a leading provider of genetic testing services in the United Arab Emirates. Our state-of-the-art facilities and experienced team of genetic counselors and medical professionals ensure that you receive accurate and comprehensive results. We understand the emotional and medical significance of genetic testing, and we are committed to providing support throughout the testing process. For more information about the ATXN10 gene spinocerebellar ataxia type 10 autosomal dominant genetic test, please visit our website at https://dnalabsuae.com/tests/atxn10-gene-spinocerebellar-ataxia-type-10-autosomal-dominant-genetic-test/.
Early diagnosis and intervention are crucial in managing the symptoms of SCA10 and improving the quality of life for those affected. If you or a family member are experiencing symptoms or have a family history of SCA10, consider speaking with a healthcare provider about the ATXN10 gene test offered by DNA Labs UAE. Understanding your genetic makeup is the first step towards effective management and treatment of spinocerebellar ataxia type 10.
